NASDAQ · Financial Statements

Zenas BioPharma, Inc. (ZBIO) Financial Statements

$26.24 NASDAQ: ZBIO Market Cap $1.66B

Zenas BioPharma, Inc. most recently reported annual revenue of $10.0M, net profit of $-378.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2022202320242025
Revenue$0$50.0M$5.0M$10.0M
Operating Profit$-76.0M$-37.0M$-164.0M$-211.0M
Net Profit$-119.0M$-37.0M$-157.0M$-378.0M
EPS$-3.11$-0.97$-3.76$-8.44
Op Margin—-74.3%-3277.8%-2113.8%

Balance Sheet (USD)

Metric2022202320242025
Total Assets$75.0M$68.0M$370.0M$384.0M
Total Liabilities$267.0M$294.0M$58.0M$141.0M
Cash$67.0M$57.0M$320.0M$111.0M
Borrowings$2.0M$21.0M$1.0M$80.0M

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-66.0M$-31.0M$-120.0M$-172.0M
Investing Cash Flow$-4.0M$0$-31.0M$-252.0M
Financing Cash Flow$0$0$-6.0M$62.0M
Net Cash Flow$-8.0M$-10.0M$263.0M$-209.0M
Free Cash Flow$-68.0M$-31.0M$-120.0M$-172.0M

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
ZBIO Overview ZBIO Dividend Run Stock Screener